Apotal IVS: Financial statements 2019
CVR: 38128566
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
Apotal IVS (CVR 38128566) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,071,887 and a net result of DKK 726,696 compared with DKK -143,715 the year before. That is an increase of 1,984.6% compared with the year before. Equity in the 2019 report amounted to DKK 495,044. The solvency ratio was 28.2%.
- Gross Profit
- DKK 1,071,887
- Profit/Loss
- DKK 726,696
- Equity
- DKK 495,044
- Total Assets
- DKK 1,754,801
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.1 mio. | 727 t. | 495 t. | - |
| 2018 | - | 51 t. | -144 t. | -232 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Apotal IVS
Apotal IVS was a Danish company of the type Iværksætterselskab based in Værløse, founded in 2016. The company has been dissolved on 10 September 2021. The company was registered under the industry Udlejning af kontormaskiner og -udstyr, computere og it-udstyr. In 2020, the company reported a gross profit of DKK 275,957 and a net result of DKK -131,265 compared with DKK 726,696 the year before. Equity in the 2020 report amounted to DKK 255,779.